Related Experiment Video
Updated: Feb 5, 2026

Developing HiPSC Derived Serum Free Embryoid Bodies for the Interrogation of 3-D Stem Cell Cultures Using Physiologically Relevant Assays
Published on: July 20, 2017
A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres
Benjamin Fischer1, Anna Meier1, Annika Dehne1
1Fraunhofer Institute for Biomedical Engineering, Joseph-von-Fraunhofer-Weg 1, Sulzbach 66280, Germany.
Insights
This study presents a new workflow for producing human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) using a dynamic suspension bioreactor. This method improves yield and viability for cardiovascular research and drug discovery.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Biotechnology
Background:
- Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are crucial for cardiovascular research, disease modeling, and drug discovery.
- Current methods for hiPSC-CM production face limitations in yield and efficiency, hindering their therapeutic and research potential.
Purpose of the Study:
- To develop a complete workflow for producing ready-to-use hiPSC-CMs in a dynamic suspension bioreactor.
- To improve the efficiency, yield, and viability of hiPSC-CM production compared to existing methods.
Main Methods:
- Utilized a dynamic suspension bioreactor for efficient and reproducible differentiation of hiPSCs into cardiospheres.
- Developed a novel papain-based dissociation method for hiPSC-CMs, offering higher yield and viability than TrypLE and Accutase.
- Performed molecular and functional analyses to confirm the identity and functionality of dissociated hiPSC-CMs.
Main Results:
- The dynamic suspension bioreactor method resulted in enhanced physiological maturation of cardiospheres compared to static 3D induction.
- The papain-based dissociation method significantly increased hiPSC-CM yield and viability.
- hiPSC-CMs retained their identity and functionality after dissociation and reseeding for downstream applications.
Conclusions:
- The presented workflow provides an efficient and scalable method for producing high-quality hiPSC-CMs.
- This optimized production of hiPSC-CMs can overcome current bottlenecks, advancing cardiovascular research, disease modeling, and drug discovery.
- The ready-to-use hiPSC-CMs are suitable for various downstream applications, including monolayer and spheroid cultures.
Abstract:
Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) are an invaluable tool for both basic and translational cardiovascular research. The potential that these cells hold for therapy, disease modeling and drug discovery is hampered by several bottlenecks that currently limit both the yield and the efficiency of cardiac induction. Here, we present a complete workflow for the production of ready-to-use hiPSC-CMs in a dynamic suspension bioreactor. This includes the efficient and highly reproducible differentiation of hiPSCs into cardiospheres, which display enhanced physiological maturation compared to static 3D induction in hanging drops, and a novel papain-based dissociation method that offers higher yield and viability than the broadly used dissociation reagents TrypLE and Accutase. Molecular and functional analyses of the cardiomyocytes reseeded after dissociation confirmed both the identity and the functionality of the cells, which can be used in downstream applications, either as monolayers or spheroids.
Related Concept Videos
Dissociative Disorders
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
Dissociative Amnesia
Dissociative Identity Disorder
Bond Dissociation Energy and Activation Energy
Acid/Base Strengths and Dissociation Constants
Measurement: Derived Units

